Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/52274
DC Field | Value | Language |
---|---|---|
dc.contributor.author | González-Lama, Z. | en_US |
dc.contributor.author | Soria, S. | en_US |
dc.contributor.author | Díez Del Pino, A. | en_US |
dc.contributor.author | Tejedor, M. T. | en_US |
dc.contributor.author | Lupiola, P. | en_US |
dc.date.accessioned | 2018-11-25T18:55:22Z | - |
dc.date.available | 2018-11-25T18:55:22Z | - |
dc.date.issued | 2001 | en_US |
dc.identifier.issn | 0074-0195 | en_US |
dc.identifier.uri | http://hdl.handle.net/10553/52274 | - |
dc.description.abstract | Four marine strains of Vibrio and Photobacterium were tested for their susceptibilities to 22 antimicrobial agents. All strains were susceptible to chloramphenicol, nalidixic acid, cotrimoxazole, tetracycline, netilmicin and norfloxacin; all were resistant to penicillin and ampicillin, and exhibited β-lactamase activity. However, there were significant differences between strains, especially in their patterns of betalactam and aminoglycosides susceptibility. Vibrio splendidus biovar 1 and Vibrio harveyi have β-lactamases of the 2d group (cloxacillin-hydrolyzing β-lactamases), Photobacterium angustum has β-lactamases of the 2b group (broad-spectrum β-lactamases inhibited by clavulanic acid), and Photobacterium phosphoreum var. K has β-lactamases of the 2c group (carbenicillin-hydrolyzing β-lactamases inhibited by clavulanic acid). | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Boletín - Instituto Español de Oceanografía | en_US |
dc.source | Boletin - Instituto Espanol de Oceanografia[ISSN 0074-0195],v. 17, p. 233-237 | en_US |
dc.subject | 3109 Ciencias veterinarias | en_US |
dc.title | In vitro antimicrobial susceptibilities and production of β-lactamases in marine Vibrio and Photobacterium | en_US |
dc.type | info:eu-repo/semantics/Article | en_US |
dc.type | Article | en_US |
dc.identifier.scopus | 0036436651 | - |
dc.contributor.authorscopusid | 56616723200 | - |
dc.contributor.authorscopusid | 6701539068 | - |
dc.contributor.authorscopusid | 6506293404 | - |
dc.contributor.authorscopusid | 57196886210 | - |
dc.contributor.authorscopusid | 7801592268 | - |
dc.description.lastpage | 237 | en_US |
dc.description.firstpage | 233 | en_US |
dc.relation.volume | 17 | en_US |
dc.investigacion | Ciencias | en_US |
dc.type2 | Artículo | en_US |
dc.utils.revision | Sí | en_US |
dc.date.coverdate | Diciembre 2001 | en_US |
dc.identifier.ulpgc | Sí | en_US |
dc.contributor.buulpgc | BU-BAS | en_US |
item.grantfulltext | none | - |
item.fulltext | Sin texto completo | - |
crisitem.author.dept | GIR IUSA-ONEHEALTH 4. Producción y Biotecnología Animal | - |
crisitem.author.dept | IU de Sanidad Animal y Seguridad Alimentaria | - |
crisitem.author.dept | Departamento de Ciencias Clínicas | - |
crisitem.author.parentorg | IU de Sanidad Animal y Seguridad Alimentaria | - |
crisitem.author.fullName | Lupiola Gómez, Pablo Antonio | - |
Appears in Collections: | Artículos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.